Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.

Murakami S, Li R, Nagari A, Chae M, Camacho CV, Kraus WL.

Mol Cancer Res. 2019 Dec;17(12):2356-2368. doi: 10.1158/1541-7786.MCR-19-0393. Epub 2019 Sep 24.

PMID:
31551256
2.

Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21.

Kim DS, Camacho CV, Nagari A, Malladi VS, Challa S, Kraus WL.

Mol Cell. 2019 Sep 19;75(6):1270-1285.e14. doi: 10.1016/j.molcel.2019.06.020. Epub 2019 Jul 24.

PMID:
31351877
3.

Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes.

Xi Y, Shi J, Li W, Tanaka K, Allton KL, Richardson D, Li J, Franco HL, Nagari A, Malladi VS, Coletta LD, Simper MS, Keyomarsi K, Shen J, Bedford MT, Shi X, Barton MC, Kraus WL, Li W, Dent SYR.

BMC Genomics. 2018 Feb 20;19(1):150. doi: 10.1186/s12864-018-4533-0.

4.

Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.

Franco HL, Nagari A, Malladi VS, Li W, Xi Y, Richardson D, Allton KL, Tanaka K, Li J, Murakami S, Keyomarsi K, Bedford MT, Shi X, Li W, Barton MC, Dent SYR, Kraus WL.

Genome Res. 2018 Feb;28(2):159-170. doi: 10.1101/gr.226019.117. Epub 2017 Dec 22.

5.

Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching.

Murakami S, Nagari A, Kraus WL.

Genes Dev. 2017 Aug 1;31(15):1535-1548. doi: 10.1101/gad.302182.117. Epub 2017 Sep 8.

6.

Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers.

Nagari A, Murakami S, Malladi VS, Kraus WL.

Methods Mol Biol. 2017;1468:121-38. doi: 10.1007/978-1-4939-4035-6_10.

7.

Interplay between inflammatory and estrogen signaling in breast cancer.

Nagari A, Franco HL.

Cytokine. 2015 Dec;76(2):588-590. doi: 10.1016/j.cyto.2015.06.012. Epub 2015 Jul 3.

PMID:
26144291
8.

Linking the aryl hydrocarbon receptor with altered DNA methylation patterns and developmentally induced aberrant antiviral CD8+ T cell responses.

Winans B, Nagari A, Chae M, Post CM, Ko CI, Puga A, Kraus WL, Lawrence BP.

J Immunol. 2015 May 1;194(9):4446-57. doi: 10.4049/jimmunol.1402044. Epub 2015 Mar 25.

9.

TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome.

Franco HL, Nagari A, Kraus WL.

Mol Cell. 2015 Apr 2;58(1):21-34. doi: 10.1016/j.molcel.2015.02.001. Epub 2015 Mar 5.

10.

Enhancer transcripts mark active estrogen receptor binding sites.

Hah N, Murakami S, Nagari A, Danko CG, Kraus WL.

Genome Res. 2013 Aug;23(8):1210-23. doi: 10.1101/gr.152306.112. Epub 2013 May 1.

Supplemental Content

Loading ...
Support Center